Equillium to present at two upcoming investor conferences

La jolla, calif.--(business wire)---- $eq #gvhd--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in a fireside chat presentation at the wells fargo healthcare conference and a corporate presentation at the h.c. wainwright annual global investment conference. management will provide a high-level overview of the company, clini
EQ Ratings Summary
EQ Quant Ranking